Optimal initiation of Helicobacter pylori eradication in patients with peptic ulcer bleeding

Table 2 Baseline demographics of patients with peptic ulcer bleeding who underwent Helicobacter pylori eradication therapy according to the time of eradication therapy initiation n (%)

	Eradication during hospitalization (n = 77)	Eradication at the OPC(n = 20)	P value
Male	59 (76.6)	17 (85.0)	0.550
Age mean ± SD (yr)	66.1 ± 13.9	59.5 ± 15.1	0.063
Disease			0.833
BGU	57 (74.0)	16 (80)
DU	9 (11.7)	1 (5.0)
BGU and DU	11 (14.3)	3 (15.0)
Eradication regimen			0.191
7-d triple therapy1	60 (77.9)	20 (100)
10-d triple therapy	2 (2.6)	0
14-d triple therapy	10 (13.0)	0
Others	5 (6.5)	0
Smoking			0.100
Current	22 (28.6)	7 (35.0)
Past	5 (6.5)	4 (20.0)
Never	50 (64.9)	9 (45.0)
Oral iron replacement during eradication therapy			0.113
Yes	30 (39.0)	4 (20.0)
No	47 (61.0)	16 (80.0)

¹Proton-pump inhibitor standard dose bid, clarithromycin 500 mg bid, and amoxicillin 1000 mg bid. BGU: Benign gastric ulcer; DU: Duodenal ulcer; H. pylori: Helicobacter pylori; OPC: Outpatient clinic; PUB: Peptic ulcer bleeding.